Combating sepsis-induced acute lung injury: PARP1 inhibition mediates oxidative stress mitigation and miR-135a-5p/SMAD5/Nanog axis drives regeneration.

PURPOSE The purpose of this study was to investigate the therapeutic potential of Poly (ADP-ribose) polymerase 1 (PARP1) inhibition combined with microRNA miR-135a-5p overexpression in sepsis-induced acute lung injury (ALI). Specifically, we aimed to elucidate combinatorial therapeutic potential of PARP1 inhibition in mitigating oxidative stress and inflammation across different models, simultaneously miR-135a-5p overexpression promoting regeneration through the SMAD5/Nanog axis. METHOD We used C57BL/6 mice to create Cecal Ligation Puncture (CLP) model of Sepsis-induced Acute Lung Injury. RAW264.7 murine macrophages and MLE12 (Mouse Lung Epithelial) cells were stimulated through Lipopolysaccharide (LPS) to induce inflammation. miR-135a-5p mimic Transfection confirmed using one-step Real time quantitative PCR (RT-qPCR). PARP1 inhibition confirmed by western blotting using Poly (ADP-ribose) (PAR) expression. Reactive oxygen Species (ROS) generation measured through Dichlorofluorescein diacetate (DCF-DA) dye using fluorescent microscopy and Nitric Oxide (NO) via spectrophotometry. Bronchoalveolar Lavage Fluid (BALF) cytokine analysis was done using Enzyme-linked immunosorbent assay (ELISA). miRNA mediated signaling, inflammatory markers and cytokines were determined using immunoblotting, RT-qPCR, and immunohistochemistry. miR-135a-5p target validation using dual-luciferase assay. RESULTS Our results demonstrated that PARP1 inhibition significantly reduced oxidative stress (**P < 0.01) and inflammatory markers in sepsis-induced lung injury models. Specifically, we observed decreased protein levels of inducible nitric oxide synthase (iNOS) (***P < 0.001), cyclooxygenase-2 (COX2) (*P < 0.05), phospho-Akt (*P < 0.05), and Tumor necrosis factor-Alpha (TNF-α) (*P < 0.05) mRNA expression. We observed significant reduction in ROS and NO generation in macrophages. Moreover, histopathological evidence suggested improved lung health. Concurrently, miR-135a-5p overexpression decreased the expression of SMAD5 (*P < 0.05) which in turns increased the expression of Nanog and related pluripotency genes in epithelial cells and mice, thus promoting regeneration and repair. CONCLUSION The combination of PARP1 inhibition and miR-135a-5p overexpression showed significant potential as a therapeutic intervention by reducing inflammation alongside stimulating regenerative environment in Sepsis-induced ALI.

• Publication year

  2025

• Venue

  International Immunopharmacology

• Publication date

  2025-01-29

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.intimp.2025.114166PMID 39884084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress

  2024cited by this paper
• Analysis of Immune and Prognostic-Related lncRNA PRKCQ-AS1 for Predicting Prognosis and Regulating Effect in Sepsis

  2024cited by this paper
• Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide

  2023cited by this paper
• Vitamin-D ameliorates sepsis-induced acute lung injury via augmenting miR-149-5p and downregulating ER stress.

  2022cited by this paper
• The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies

  2021cited by this paper
• Long non-coding RNA (lncRNA): A potential therapeutic target in acute lung injury

  2021cited by this paper
• Acute lung injury - from pathophysiology to treatment.

  2021cited by this paper
• Poly(ADP-ribose) polymerase inhibition: past, present and future

  2020cited by this paper
• Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis

  2020cited by this paper
• Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

  2020cited by this paper
• Identification and Validation of Potential miRNAs, as Biomarkers for Sepsis and Associated Lung Injury: A Network-Based Approach

  2020cited by this paper
• MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression

  2019cited by this paper
• Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-κB and HMGB1 pathways through the upregulation of SIRT1

  2017cited by this paper
• Acute Respiratory Distress Syndrome

  2017cited by this paper
• Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

  2017cited by this paper
• New insights into vitamin D anticancer properties: focus on miRNA modulation

  2017cited by this paper
• Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs

  2017cited by this paper
• MicroRNAs in metabolism

  2016cited by this paper
• Acute Respiratory Distress Syndrome

  2016cited by this paper
• In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

  2016cited by this paper
• Sepsis and septic shock

  2016cited by this paper
• Tissue damage and senescence provide critical signals for cellular reprogramming in vivo

  2016cited by this paper
• TGF-β signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation.

  2014cited by this paper
• Role of extracellular and intracellular microRNAs in sepsis.

  2014cited by this paper
• Lung regeneration: mechanisms, applications and emerging stem cell populations

  2014cited by this paper
• PARP-1 Inhibitor, DPQ, Attenuates LPS-Induced Acute Lung Injury through Inhibiting NF-κB-Mediated Inflammatory Response

  2013cited by this paper
• Poly(ADP-ribose): PARadigms and PARadoxes.

  2013cited by this paper
• Type 2 alveolar cells are stem cells in adult lung.

  2013cited by this paper
• TNF-α signalling and inflammation: interactions between old acquaintances

  2013cited by this paper
• MicroRNA regulation of T‐cell differentiation and function

  2013cited by this paper
• New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

  2012cited by this paper
• Role of poly(ADP‐ribose) polymerases in the regulation of inflammatory processes

  2012cited by this paper
• TGFβ signalling in context

  2012cited by this paper
• Epithelial progenitor cells in lung development, maintenance, repair, and disease.

  2011cited by this paper
• The acute respiratory distress syndrome: pathogenesis and treatment.

  2011cited by this paper
• An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.

  2011cited by this paper
• Cecal ligation puncture procedure.

  2011cited by this paper
• Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment

  2010cited by this paper
• Biogenesis of small RNAs in animals

  2009cited by this paper
• Epidermal homeostasis: a balancing act of stem cells in the skin

  2009cited by this paper
• Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

  2008cited by this paper
• The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases.

  2008cited by this paper
• Harmful molecular mechanisms in sepsis

  2008cited by this paper
• A microRNA signature for a BMP2-induced osteoblast lineage commitment program

  2008cited by this paper
• Immunodesign of experimental sepsis by cecal ligation and puncture

  2008cited by this paper
• An extended transcriptional network for pluripotency of embryonic stem cells.

  2008cited by this paper
• Nanog safeguards pluripotency and mediates germline development

  2007cited by this paper
• Poly(ADP-ribose): novel functions for an old molecule

  2006cited by this paper
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006cited by this paper
• The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Core transcriptional regulatory circuitry in human embryonic stem cells.

  2005cited by this paper
• Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells

  2005cited by this paper
• BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3.

  2003cited by this paper
• Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.

  2003cited by this paper
• Resistance to Acute Septic Peritonitis in Poly(ADP-ribose) Polymerase-1-Deficient Mice

  2002cited by this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• The immunopathogenesis of sepsis

  2002cited by this paper
• Smad regulation in TGF-beta signal transduction.

  2001cited by this paper
• Inducible Nitric Oxide Synthase and Inflammatory Diseases

  2000cited by this paper
• Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

  2000cited by this paper
• Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

  1999cited by this paper
• Role and regulation of cyclooxygenase-2 during inflammation.

  1999cited by this paper
• Stem Cells , the Molecular Circuitry of Pluripotency and Nuclear Reprogramming

  year unknowncited by this paper

• No citing papers are available for this paper.